Evidence map›Paper›PMID 33467090›Full record

ArticlePharmaceutics2021

Evaluation of the Hemocompatibility and Anticancer Potential of Poly(

Eleftherios Halevas, Chrysoula Kokotidou, Elda Zaimai, Alexandra Moschona, Efstratios Lialiaris, Anna Mitraki, Theodore Lialiaris, Anastasia Pantazaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eleftherios HalevasInstitute of Biosciences & Applications, National Centre for Scientific Research "Demokritos", 15310 Athens, Greece.ORCID 0000-0002-6803-5395
Chrysoula KokotidouDepartment of Materials Science and Technology, University of Crete, Voutes Campus, 70013 Heraklion, Greece.ORCID 0000-0003-4825-9022
Elda ZaimaiLaboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Alexandra MoschonaLaboratory of Organic Chemistry, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Efstratios LialiarisLaboratory of Genetics, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Anna MitrakiDepartment of Materials Science and Technology, University of Crete, Voutes Campus, 70013 Heraklion, Greece.
Theodore LialiarisLaboratory of Genetics, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Anastasia PantazakiLaboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Funding

Foundation for Education and European Culture -Stavros Niarchos Foundation -
6 · The paper itself

Abstract

In this work, novel chrysin-loaded poly(

Indexed as

anticancer activitychrysindrug micro-encapsulation and deliveryhuman blood compatibilitypoly(ε-caprolactone) and poly(3-hydroxybutyrate) biodegradable polymers

Identifiers

PMID33467090
PMCPMC7831015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.